-
Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder.
Hart AB, Gamazon ER, Engelhardt BE, Sklar P, Kähler AK, Hultman CM, Sullivan PF, Neale BM, Faraone SV; Psychiatric Genomics Consortium: ADHD Subgroup, de Wit H, Cox NJ, Palmer AA. Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder. Proc... llegir més
-
Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults.
Ramos-Quiroga JA, Nasillo V, Fernández-Aranda F, Casas M. Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother. 2014 May;14(5):553-67. doi: 10.1586/14737175.2014.908708. Epub 2014 Apr 17. Erratum in: Expert Rev Neurother. 2014 Jun;14(6):717. Fernández-Arana,Fernando [corrected to Fernández-Aranda,... llegir més
-
Prevalence of attention deficit/hyperactivity disorder symptoms in outpatient adolescents and young adults with other psychiatricdisorders refractory to previous treatments.
Vidal R, Barrau V, Casas M, Caballero-Correa M, Martínez-Jiménez P,Ramos-Quiroga JA. Prevalence of attention deficit/hyperactivity disorder symptoms in outpatient adolescents and young adults with other psychiatricdisorders refractory to previous treatments. Rev Psiquiatr Salud Ment. 2014Jul-Sep;7(3):104-12. doi: 10.1016/j.rpsm.2014.03.003. Epub 2014 Jun... llegir més
-
Emotional lability: The discriminative value in the diagnosis of attention deficit/hyperactivity disorder in adults
Vidal R, Valero S, Nogueira M, Palomar G, Corrales M, Richarte V, Bosch R, Gómez-Barros N, Corominas M, Casas M, Ramos-Quiroga JA. Emotional lability: The discriminative value in the diagnosis of attention deficit/hyperactivity disorder in adults. Compr Psychiatry. 2014 Oct;55(7):1712-9. doi:10.1016/j.comppsych.2014.07.001. Epub 2014 Jul 7. PubMed PMID:... llegir més